KYORIN Pharmaceutical Co., Ltd.
4569 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区大手町一丁目３番７号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
KYORIN Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that operates as a subsidiary of KYORIN Holdings, Inc. Following a merger in April 2023, the company adopted its current name, reflecting its commitment to innovation and excellence in the healthcare sector. KYORIN specializes in research and development of pharmaceuticals, focusing on areas such as respiratory, otolaryngology, and urology. The company aims to enhance the quality of life for patients by providing effective medications and solutions. With a strong emphasis on scientific research and collaboration, KYORIN is dedicated to advancing healthcare through its comprehensive portfolio of products and its commitment to improving patient outcomes.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 07:25 |
Inside Information Statement
臨時報告書
|
Japanese | 23.5 KB | |
| 2025-06-19 08:55 |
Internal Control over Financial Reporting
内部統制報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 27.1 KB | |
| 2025-06-19 08:53 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-06-19 08:50 |
Annual Report
有価証券報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 1.4 MB | |
| 2024-11-13 07:27 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-13 07:24 |
Interim Report
半期報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 216.2 KB | |
| 2024-06-28 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 23.5 KB | |
| 2024-06-24 08:53 |
Internal Control over Financial Reporting
内部統制報告書－第66期(2023/04/01－2024/03/31)
|
Japanese | 24.3 KB | |
| 2024-06-24 08:51 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-06-24 08:47 |
Annual Report
有価証券報告書－第66期(2023/04/01－2024/03/31)
|
Japanese | 1.3 MB | |
| 2024-02-14 07:07 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-02-14 07:05 |
Quarterly Report
四半期報告書－第66期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 190.9 KB | |
| 2023-11-14 07:36 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2023-11-14 07:34 |
Quarterly Report
四半期報告書－第66期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 189.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GNI Group Ltd. | Japan | 2160 | |
|
Gour Medical | France | MLGML | |
|
Grifols S.A. | Spain | GRF | |
|
Grindeks | Latvia | GRD1R | |
|
Guerbet | France | GBT | |
|
Haemato AG | Germany | HAEK | |
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
HEALIOS K.K. | Japan | 4593 |